What is NineThirty?

NineThirty is an intelligent stock screening and backtesting platform tailored for US equities and ETFs, empowering users to articulate their strategies in straightforward terms while it automatically constructs filtering logic that uses more than 40 customizable technical indicators. It further enhances analysis by incorporating over 20 fundamental metrics sourced from income statements, cash flows, and balance sheets, alongside sentiment-filtered news. The tool also takes into account corporate actions, including insider trading, and allows users to combine conditions with AND and OR logic, thereby representing the entire setup in a cohesive expression tailored to specific time bars. Users are not confined to preset intervals, as they can choose custom candle sizes that range from minutes to longer durations. Once a screening setup is established, backtesting can be performed to assess its effectiveness, providing insights into the frequency of triggers, historical win rates, average returns, optimal holding durations, and a comprehensive trade log that captures maximum favorable and adverse excursions for each instance. This approach grants valuable historical insights, albeit with the usual limitations of hindsight, rather than acting as a straightforward trading signal. Additionally, the platform features DrMarket, an AI analyst supported by multiple agents ready to address queries about live setups derived from first-party data, ensuring that every statistic is thoroughly linked back to its origin for accountability. This holistic methodology guarantees that investors are equipped with accurate and detailed information to inform their investment decisions, ultimately enhancing their confidence in the stock market.

Pricing

Price Starts At:
$19.90/month
Free Version:
Free Version available.

Integrations

No integrations listed.

Screenshots and Video

screener

screener

Company Facts

Company Name:
Tradomate One
Date Founded:
2025
Company Website:
ninethirty.ai
Edit This Page

Product Details

Deployment
SaaS
Support
Web-Based Support

Product Details

Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English

NineThirty Categories and Features

NineThirty Customer Reviews

Write a Review
  • Reviewer Name: A Verified Reviewer
    Position: Accountant
    Has used product for: Free Trial
    Uses the product: Daily
    Org Size (# of Employees): 5,000 - 9,999
    Feature Set
    Layout
    Ease Of Use
    Cost
    Customer Service
    Would you Recommend to Others?
    1 2 3 4 5 6 7 8 9 10

    Their Dr.market feature is brilliant

    Date: Aug 26 2026
    Summary

    Easy, efficient and worth it. The platform is very easy to use and understand. I highly recommend it to traders, especially equity traders or investors.

    Positive

    The way Dr Market gave me the market analysis it's data-backed and easy to use. The chart comparison feature stands out to me.
    It feels like a personalised workspace for traders. The screener and stock validation are there; news with sentiment is there, as well as a stock events tracker and seasonality. If you're done with jumping between 5-6 tabs while doing market research, then this is for you.

    Negative

    The pricing is so cheap 😂, with this quality analysis they should charge more.

    Read More...
  • Previous
  • You're on page 1
  • Next